New York Life Investments Activ Stock Price: Quote, Forecast, Splits & News (MMSD)

ProPhase Labs Eyes Strategic Sale Amid Nasdaq Compliance Efforts

13 hours ago

ProPhase Labs announced a significant shift in its business model for Q1 2025, aiming to streamline operations and reduce risk. The company is actively pursuing the sale of its Nebula Genomics subsidiary, with outreach to potential buyers underway. ProPhase expects to secure a Nasdaq listing extension despite ongoing stock price concerns.

Cincinnati Financial Gains Analyst Confidence as Shares Edge Higher

5 hours ago

Cincinnati Financial stock climbed 1% to $150.86, buoyed by recent analyst upgrades and a consensus 'moderate buy' rating. The insurer’s strong fundamentals, including a low debt-to-equity ratio and positive earnings outlook, have contributed to its appeal among investors. Several analysts recently raised their price targets, reflecting optimism about future growth.

New York Life Investments Expands ETF Suite with Short-Term Muni Fund

May 6, 2025

New York Life Investments has launched the NYLI MacKay Muni Short Duration ETF (MMSD), targeting high-quality, short-term municipal bonds with a 1-3 year duration. The actively managed fund allows up to 20% in non-investment grade bonds, offering flexibility for income-seeking investors amid shifting interest rates and market uncertainty.

Go Deeper

Related

Go Deeper